Photobiological regulation therapeutic instrument for treating age-related macular degeneration and use method
Patent Information
- Authority / Receiving Office
- CN Β· China
- Current Assignee / Owner
- FIRST AFFILIATED HOSPITAL OF KUNMING MEDICAL UNIV
- Publication Date
- 2021-04-20
Smart Images

Figure 1
Abstract
Description
technical field
[0001] The invention relates to a treatment device for age-related macular degeneration, in particular to a photobiomodulation treatment device for treating age-related macular degeneration and its application method. Background technique
[0002] Age-related macular degeneration (AMD) is an eye disease whose incidence is positively correlated with age. The medical community generally believes that the degeneration of photoreceptors and retinal pigment cells (RPE cells) in the macular area of ββthe retina is one of the pathogenic factors of AMD. As one of the irreversible blinding eye diseases, statistics show that 8.7% of the world's population suffers from AMD. With the increasing aging of the global population, the health and medical expenses for AMD treatment in various countries will also increase year by year. Clinically, AMD is divided into atrophic (dry) and exudative (wet) according to different phenotypes, mainly in patients with dry AMD, and dry AM...